Need Access?
If you are a licensed provider and would like to access the Practitioner List, or your payment statements please e-mail nlpdp@bell.ca to request a USERNAME and PASSWORD.

 
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Benefit list updates_New additions_BRAFTOVI 75mg and MEKTOVI 162023-Jan-26Word PDF
Short-Stock: Amphetamine Mixed Salts 30mg152023-Jan-26Word PDF
NLPDP Benefit Status Effective February 1, 2023142023-Jan-25Word PDF
NIDPF Vol. 87 Supplement Effective February 1, 2023 - Refer to Bulletin #14 for Benefit Status132023-Jan-25Word PDF
Benefit List Update: New Addition: Rinvoq122023-Jan-23Word PDF
Benefit List Update_Open Benefit_PMS- Hydromorphone 1mg/ml Sirop112023-Jan-19Word PDF
Short-Stock: Tobramycin 0.3 percent Ophthalmic102023-Jan-19Word PDF
Short-Stock: Morphine Sulfate SR 30 mg92023-Jan-17Word PDF
Short-Stock: Spironolactone 25mg82023-Jan-13Word PDF
Benefit list updates_New Additions to Existing Category_LENALIDOMIDE.72023-Jan-12Word PDF
Short-Stock: Budesonide 0.25mg/ml62023-Jan-11Word PDF
Updated - Benefit List Update: New Addition to an existing category: Vyndamax32023-Jan-09Word PDF
Short-Stock: Budesonide 0.5mg/ml52023-Jan-05Word PDF
Short-Stock: Spironolactone 100mg42023-Jan-05Word PDF
Benefit List Update: New Addition: Semglee and Kirsty22023-Jan-05Word PDF
Short-Stock: Sitagliptin/Meformin Hydrochloride 50mg/1000mg12023-Jan-04Word PDF
Benefit Status Update: Drugs Reviewed and Not Recommended for Funding under NLPDP1892022-Dec-30Word PDF
Online version of NIDPF Vol. 87 effective January 1, 20231882022-Dec-30Word PDF
Update - Short-Stock: Tretinoin 10mg1872022-Dec-30Word PDF
Update - Benefit List Update: Addition to Levofloxacin Tablets1862022-Dec-29Word PDF
Page  Go
Page 1 of 52
Document Name: Date Range: To


Document NameDateView
Coverage Status Table - January 20232023-Jan-24 PDF
Coverage Status Table - December 20222022-Dec-14 PDF
Coverage Status Table - November 20222022-Nov-15 PDF
Coverage Status Table - October 20222022-Oct-11 PDF
Coverage Status Table - September 20222022-Sep-14 PDF
Coverage Status Table - August 20222022-Aug-25 PDF
Coverage Status Table - July 20222022-Jul-19 PDF
Coverage Status Table - June 2022 2022-Jun-28 PDF
Coverage Status Table - May 2022 2022-May-13 PDF
Coverage Status Table - April 20222022-Apr-27 PDF
Coverage Status Table - March 20222022-Mar-25 PDF
Coverage Status Table - February 20222022-Feb-18 PDF
Coverage Status Table - January 20222022-Jan-25 PDF
Coverage Status Table - December 20212021-Dec-10 PDF
Coverage Status Table - November 20212021-Nov-05 PDF
Coverage Status Table - September 20212021-Sep-02 PDF
Coverage Status Table - July 20212021-Jul-22 PDF
Coverage Status Table - June 20212021-Jun-24 PDF
Coverage Status Table - May 20212021-May-19 PDF
Coverage Status Table - April 20212021-Apr-23 PDF
Page  Go
Page 1 of 2
Document Name: Date Range: To


Document NameDateView
Diabetic Listing - December 13, 20222022-Dec-14 PDF
Diabetic Listing - June 15, 2022 (Refer to Bulletin #82 posted on June 15, 2022)2022-Jun-15Word PDF
Diabetic Listing - March 18, 2022 (Refer to Bulletin #39 posted on March 18, 2022)2022-Mar-21Word PDF
Diabetic Listing - March 2, 2022 (Refer to Bulletin #35 posted on March 2, 2022)2022-Mar-02Word PDF
Diabetic Listing - January 13, 2022 (Refer to Bulletin #4 posted on January 13, 2022)2022-Jan-13Word PDF
Diabetic Listing - January 10, 2022 (Refer to Bulletin #2 posted on January 10, 2022)2022-Jan-10Word PDF
 
Page 1 of 1
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Benefit list updates_New additions_BRAFTOVI 75mg and MEKTOVI 162023-Jan-26Word PDF
Benefit List Update: New Addition: Rinvoq122023-Jan-23Word PDF
Benefit List Update_Open Benefit_PMS- Hydromorphone 1mg/ml Sirop112023-Jan-19Word PDF
Benefit list updates_New Additions to Existing Category_LENALIDOMIDE.72023-Jan-12Word PDF
Benefit List Update: New Addition to an existing category: Vyndamax32023-Jan-09Word PDF
Benefit List Update: New Addition: Semglee and Kirsty22023-Jan-05Word PDF
Benefit Status Update: Drugs Reviewed and Not Recommended for Funding under NLPDP1892022-Dec-30Word PDF
Benefit List Update: New Addition: Tysabri1832022-Dec-19Word PDF
Benefit List Update_Criteria Update_Cabergoline 0.5mg Table1802022-Dec-14Word PDF
Benefit List Update: Special Authorization Criteria update: Levemir 1792022-Dec-14Word PDF
Benefit List Update: OPEN benefit_Micronized Progesterone 100mg1772022-Dec-14Word PDF
Benefit list updates_New Additions to Existing Category_Non-Insulin Anti-Diabetic Agents1752022-Dec-08Word PDF
Benefit List Update: New Addition: Breztri Aerosphere1742022-Dec-07Word PDF
Benefit List Update: Addition to Propylthiouracil 50mg Tablets1732022-Dec-06Word PDF
Benefit List Update: Delisting of Omega Glycopyrrolate 0.2mg/ml Injection1712022-Dec-02Word PDF
Benefit List Update: New Additions to Glycopyrrolate and Furosemide Injection1702022-Dec-02Word PDF
Benefit list update: new addition to an existing category: Kesimpta 1672022-Nov-28Word PDF
Benefit list update: new addition to an existing category: Xolair 150mg/ml prefilled syringe1662022-Nov-28Word PDF
Benefit List Update: New additions Crysvita1612022-Nov-21Word PDF
Benefit List Update: Ethinyl Estradiol/Cyproterone 35mcg/2mg Tablets1602022-Nov-18Word PDF
Page  Go
Page 1 of 7
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Short-Stock: Amphetamine Mixed Salts 30mg152023-Jan-26Word PDF
Short-Stock: Tobramycin 0.3 percent Ophthalmic102023-Jan-19Word PDF
Short-Stock: Morphine Sulfate SR 30 mg92023-Jan-17Word PDF
Short-Stock: Spironolactone 25mg82023-Jan-13Word PDF
Short-Stock: Budesonide 0.25mg/ml62023-Jan-11Word PDF
Short-Stock: Budesonide 0.5mg/ml52023-Jan-05Word PDF
Short-Stock: Spironolactone 100mg42023-Jan-05Word PDF
Short-Stock: Sitagliptin/Meformin Hydrochloride 50mg/1000mg12023-Jan-04Word PDF
Update - Short-Stock: Tretinoin 10mg1872022-Dec-30Word PDF
Short-Stock: Tretinoin 10mg1822022-Dec-16Word PDF
Update - Short-Stock: Tobramycin 60mg/ml1812022-Dec-16Word PDF
Short-Stock: Pazopanib 200mg1782022-Dec-14Word PDF
Short-Stock: Methylphenidate HCL 54 mg1722022-Dec-06Word PDF
Update - Short-Stock: Dorzolamide 20mg/ml1692022-Dec-02Word PDF
Update - Short-Stock: Dorzolamide 20mg/ml1622022-Nov-21Word PDF
Short-Stock: Dorzolamide 20mg/ml1582022-Nov-09Word PDF
Short-Stock: Cefixime 100mg/5ml1572022-Nov-09Word PDF
Update - Short-Stock: Methylphenidate HCL 54 mg1562022-Nov-04Word PDF
Update - Short-Stock: Methylphenidate HCL 36 mg1522022-Oct-21Word PDF
Update - Short-Stock: Methylphenidate HCL 18 mg1512022-Oct-21Word PDF
Page  Go
Page 1 of 5
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
NLPDP Benefit Status Effective February 1, 2023142023-Jan-25Word PDF
NIDPF Vol. 87 Supplement Effective February 1, 2023 - Refer to Bulletin #14 for Benefit Status132023-Jan-25Word PDF
Online version of NIDPF Vol. 87 effective January 1, 20231882022-Dec-30Word PDF
NLPDP Benefit Status Effective January 1, 20231852022-Dec-20Word PDF
NIDPF Vol. 87 Supplement Effective January 1, 2023 - Refer to Bulletin #185 for Benefit Status1842022-Dec-20Word PDF
Online version of NIDPF Vol. 87 effective December 1, 20221682022-Dec-01Word PDF
NLPDP Benefit Status Effective December 1, 20221652022-Nov-24Word PDF
NIDPF Vol. 87 Supplement Effective December 1, 2022 - Refer to Bulletin #165 for Benefit Status1642022-Nov-24Word PDF
Online version of NIDPF Vol. 87 effective November 1, 20221542022-Nov-01Word PDF
NLPDP Benefit Status Effective November 1, 20221472022-Oct-20Word PDF
NIDPF Vol. 87 Supplement Effective November 1, 2022 - Refer to Bulletin #147 for Benefit Status1462022-Oct-20Word PDF
Online version of NIDPF Vol. 87 effective October 1, 20221332022-Sep-29Word PDF
Delistings from NIDPF and NLPDP Benefit List Effective October 1, 20221292022-Sep-16Word PDF
NLPDP Benefit Status Effective October 1, 20221282022-Sep-15Word PDF
NIDPF Vol. 87 Supplement Effective October 1, 2022 - Refer to Bulletin #128 for Benefit Status1272022-Sep-15Word PDF
Online version of NIDPF Vol. 86 effective September 1, 20221242022-Sep-01Word PDF
NLPDP Benefit Status Effective September 1, 20221222022-Aug-25Word PDF
NIDPF Vol. 86 Supplement Effective September 1, 2022 - Refer to Bulletin #122 for Benefit Status1212022-Aug-25Word PDF
Online version of NIDPF Vol. 86 effective August 1, 20221122022-Jul-29Word PDF
NLPDP Benefit Status Effective August 1, 20221062022-Jul-22Word PDF
Page  Go
Page 1 of 5
Document Name: Date Range: To


Document NameDateView
2023 - Payment Schedule2022-Dec-05Word PDF
2022 - Payment Schedule2021-Dec-06Word PDF
 
Page 1 of 1